Showing 106 of 106on this page. Filters & sort apply to loaded results; URL updates for sharing.106 of 106 on this page
Verdiva Bio Launches With $411M to Propel Weekly-Dosed GLP-1 Obesity Drug
Verdiva Bio | LinkedIn
🚀🚨🚀 I’m excited to have joined the Verdiva Bio team, developing next ...
Verdiva Bio received US$410,000,000 in a sensational growth funding ...
Verdiva Bio on LinkedIn: #launch #cardiometabolic #obesity #innovation ...
Verdiva Bio
Sciwind Biosciences y Verdiva Bio se unen para llevar terapias ...
Verdiva Bio Joins Society for Clinical Research Sites (SCRS) as a ...
Verdiva Bio Announces Completion of Enrollment for EVOLVE-2 Phase 2b ...
Congratulations to Verdiva Bio on its launch today! A pleasure ...
Verdiva Bio funding news -Cardiometabolic Company Verdiva Bio Launches ...
Verdiva Bio launches with $411M Series A raise for next-gen oral and ...
Verdiva Bio | Forbion | Forbion
Verdiva Bio 2026 Company Profile: Valuation, Funding & Investors ...
Verdiva Bio to Present New Data Highlighting Once-Weekly Potential of ...
Verdiva Bio joins weight loss race with $411M Series A - PitchBook
Verdiva Bio launches with over $410 million in Series A financing to ...
Verdiva Bio raises $411m for obesity pipeline | pharmaphorum
Sciwind’s Verdiva Bio deal earnings could top $2.4 billion | The ...
Verdiva Bio - Vigo Consulting
Verdiva Bio secured US$410,000,000 in an epic growth funding round ...
Verdiva Bio completes enrolment for oral GLP-1 trial - Drug Discovery ...
#fierce15 #biotech #innovation #potential | Verdiva Bio
#launch #cardiometabolic #obesity #innovation | Verdiva Bio
Verdiva Bio launches with largest ever UK/EU Series A financing ...
Verdiva Bio Shatters Records with $411M Series A to Revolutionize ...
Verdiva Bio Emerges as a Leader in Cardiometabolic Innovation ...
Verdiva Bio launches with $411m in funding to advance obesity drugs ...
Verdiva Bio, a New Clinical-Stage Cardiometabolic Company, Launches ...
Verdiva launches with $410M for weight loss drugs to challenge Ozempic ...
Verdiva Bio's lead amylin program: insights from BioCentury Inc ...
Verdiva Bio, obesity startup, raises $400M Series A round
Verdiva Bio: Cardiometabolic Company Raises Over $410 Million (Series A)
Verdiva Bio: 410 Mio. $ GLP-1 Investment & Whatnot 265 Mio ...
Celebrating International Women’s Day with a talented team | Verdiva ...
Verdiva starts up with $411M and a portfolio of obesity drugs from ...
Europe's 10 biggest healthtech deals in H1 2025 - Tech.eu
奥博资本_投资机构 - 企查查
Verdiva携手先为达，布局全球代谢病市场，加速肥胖及心血管新药研发_摩熵医药
国产创新药出海交易TOP30（2025年1-9月）
/d10o6nnig0wrdw.cloudfront.net/03-30-2026/t_26127b7a28754a17a6a8f39c4da006eb_name_The_Morning_Filter_Thumbnail___Earnings_scaled.jpg)
